nivolumab in hnscc
Published 7 years ago • 220 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
4:35
patient selection for nivolumab in hnscc
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
6:19
nivolumab-related efficacy and toxicity in hnscc patients
-
1:34
dr. ferris discusses nivolumab in head and neck cancer
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
1:36
dr. ferris on potential of nivolumab in head and neck cancer
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
1:53
depend: nivolumab with chemotherapy and response-stratified crt in hnscc
-
1:17
dr. ferris on fda approval of nivolumab in patients with head and neck cancer
-
4:43
nivolumab in renal cell carcinoma
-
2:07
study results for nivolumab and pembrolizumab in head and neck cancer
-
0:40
dr. vokes on selecting nivolumab or pembrolizumab for head and neck cancer treatment
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
4:50
ipilimumab/nivolumab in first-line mrcc
-
1:33
dr. mcdermott on single-agent nivolumab in rcc
-
4:49
emerging nivolumab strategies in gastric/gej cancers
-
11:42
nivolumab in renal cell carcinoma
-
6:52
nivolumab in renal cell carcinoma
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer